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Abstract 
Ageing has pronounced effects on the immune system, including on innate immune cells. 
Whilst most studies suggest that total numbers of different innate immune cell populations do 
not change dramatically during ageing, many of their functions such as phagocytosis, antigen 
presentation and inflammatory molecule secretion decline. In contrast, many endogenous 
damage-associated molecular patterns (DAMPs) accumulate during ageing. These include 
reactive oxygen species (ROS) released from damaged mitochondria, extracellular 
nucleotides like ATP, high mobility group box (HMGB) 1 protein, the receptor for advanced 
glycation end products, oxidized low density lipoprotein, amyloid-beta (Aβ), islet amyloid 
polypeptide and particulates like monosodium urate (MSU) crystals and cholesterol crystals. 
Some of these DAMPs trigger the activation of inflammasomes, cytosolic danger sensing 
signalling platforms that drive both the maturation of specific pro-inflammatory mediators 
such as IL-1β, as well as the initiation of pro-inflammatory pyroptotic cell death. Herein, we 
review the evidence that dysregulated inflammasome activation, via altered innate immune 
cell functions and elevated levels of DAMPs, contributes to the establishment of chronic, 
low-grade inflammation (characterized by elevated levels of IL-6 and C-reactive protein) and 
the development of age-related pathological processes.  
 
 
Highlights 
• Many functions of innate immune cells decline during ageing.   
• Certain DAMPs and pro-inflammatory mediators increase during ageing. 
• Ageing may be linked with dysregulated inflammasome responses.  
• Controlling inflammasome activation may limit age-related pathologies.  
 
 
 
Keywords: Autophagy, DAMPs, inflammasome, inflammation, Nod-like Receptors, Pattern 
Recognition Receptors 
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1. Introduction 
Links between ageing and health decline have provided an enduring fascination throughout 
human history. The Greek philosopher Aristotle (384-322 BC) held the view that the human 
body had a specific amount of heat that was lost with age, and thus ageing brought 
vulnerability to illness. The Roman physician Galen of Pergamum (131-201 AC) considered 
that ageing was not a disease, but rather a peculiar state between health and illness (Grant, 
1963). The relationship between ageing and health deterioration still intrigues many modern 
day researchers who are now focused on identifying causative molecular mechanisms. It is 
well known that susceptibility to infectious diseases increases with age, as does the severity 
of the associated pathology. For example, there is a higher prevalence of death due to 
infection, particularly pneumonia and viral infections, in elderly people as compared to 
younger individuals (Blot, et al., 2009, Marston, et al., 1997, Thompson, et al., 2003). Indeed, 
in the USA, 90% of patients who die from pneumonia are over the age of 65 years (Mouton, 
et al., 2001). Perturbations in immune functions are likely to be central to age-related 
infectious disease susceptibility and severity, and indeed, immune dysregulation is thought to 
contribute to many age-related illnesses. Of interest in this regard is the innate immune 
system, which not only provides the first line of defence against infectious diseases, but also 
drives much of the pathology in chronic diseases.  
 
Integral to innate immune cell activation are germline-encoded pattern recognition receptors 
(PRRs) that sense danger in the form of exogenous microbe-associated molecular patterns 
(MAMPs) and endogenous damage-associated molecular patterns (DAMPs) (Kumar, et al., 
2011). Some PRRs, particularly certain members of the Nod-like Receptor (NLR) family of 
PRRs, form a cytoplasmic signalling complex called the inflammasome in response to 
specific MAMPs and DAMPs. Activation of this signalling pathway results in both the 
release of the pro-inflammatory cytokines interleukin (IL)-1β and IL-18, as well as the 
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initiation of pyroptotic cell death. In this review, we provide an overview of the impact of 
ageing on the functions of different innate immune cell populations. Specifically, we review 
the evidence linking ageing to a decline in certain innate immune functions, as well as 
elevated levels of specific DAMPs. We propose that these changes contribute to dysregulated 
inflammasome function, which drives chronic, low-grade inflammation that is characterized 
by elevated levels of specific inflammatory mediators such as IL-6. This sustained 
inflammatory state in turn contributes to the development of age-associated pathologies 
(Figure 1). 
 
2. Effects of ageing on cellular and soluble mediators of immunity 
2.1 Effects of ageing on acquired immunity 
Age-related defects in immunity could result from perturbations in the numbers and/or 
functions of specific immune cell populations. Studies that have analyzed the white blood 
cell composition of elderly people suggest that, although the total number of leukocytes does 
not vary dramatically, ageing does affect numbers of specific immune cell populations 
(Desai, et al., 2010) (Figure 2). For example, lymphocyte numbers decline with age and, in 
mouse, this is linked to a reduction in B cell output from bone marrow (Miller and Allman, 
2003), as well as a diminution in the naïve T cell output from the thymus (Linton and 
Dorshkind, 2004). In parrallel to this decline in naïve lymphocytes, the proportion of memory 
T cell populations increases in the tissues and the bone marrow (Herndler-Brandstetter, et al., 
2012, Kovaiou, et al., 2005). This may be driven, at least in part, by persistent viral infections  
(Salam, et al., 2013). As a consequence, the reduced number of naïve T cells and reduced T 
cell receptor diversity leads to increased susceptibility to infections from new pathogens, an 
impaired ability to respond to new infections and a diminished response to vaccination 
(Nikolich-Zugich, 2008). Moreover, the accumulation of memory lymphocytes can 
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predispose to the development of autoimmune diseases (Goronzy and Weyand, 2003). Not 
surprisingly then, much of the literature on immune function during ageing focuses on 
acquired immunity. In contrast, we focus this review on changes in innate immunity during 
ageing. Indeed, lymphocyte perturbations may be a consequence, in part, of age-related 
dysregulation in innate immune cell functions such as cytokine production, antigen 
presentation and inflammasome function.  
 
2.2 Age-related changes in innate immune cell populations and their functions 
Ageing affects numbers and/or functions of certain populations of innate immune cells. Mast 
cells play key roles in responses to allergens and large extracellular pathogens, and also 
regulate wound healing through their capacity for IgE-dependent release of potent 
inflammatory mediators such as histamine and tumour necrosis factor (TNF). The number of 
mast cells is reduced with age (Asboe-Hansen, 1968), and a recent study (Tsuboi, et al., 
2012) suggests this decline is due to inefficient replenishment. Reduced expression of c-Kit, 
the receptor for stem cell factor, was also observed in 10 week old mice as compared to 6 
week old mice, and this correlated with a reduction in numbers of dermal mast cells (Hart, et 
al., 1999). Since the stem cell factor/c-Kit axis is essential for mast cell development 
(Okayama and Kawakami, 2006), this provides one possible explanation for reduced mast 
cell replenishment. The functions of mast cells also appear to alter with age. In contrast to 
mast cells from young mice, those from old mice responded robustly to prostaglandin E2, 
with more pronounced prostaglandin E receptor-dependent degranulation (Nguyen, et al., 
2005). The authors thus proposed that as an organism ages, mast cell sensitivity to specific 
inflammatory mediators increases.  
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Like mast cells, eosinophils also contribute to parasite control and allergen-induced 
pathology. However, there is less evidence of perturbations in these cells during ageing. For 
example, no variation in eosinophil numbers in the sputum of asthmatics was found between 
young and elderly patients (Vignola, et al., 2003). However, one study did report a significant 
decrease in IL-5-mediated degranulation in peripheral blood eosinophils from elderly 
asthmatic patients (average age 67 versus 30 years) (Mathur, et al., 2008). The same study 
also showed that other functions, such as superoxide production, adherence and chemotaxis, 
were not altered. 
 
In contrast to the lack of evidence for eosinophil perturbation, substantial evidence links 
ageing with effects on neutrophils, granulocytes that are the most abundant leukocyte 
population in human blood. Although no differences were observed between young and 
elderly people in neutrophil numbers or granulocyte colony-stimulating factor-induced 
neutrophil production (Price, et al., 1996), various neutrophil functions are reported to be 
altered during ageing. For example, neutrophil phagocytic capacity was lower in the elderly 
(>65 years) than in younger subjects (23-35 years), as was expression of CD16/Fc gamma 
receptor III (Butcher, et al., 2001). Importantly, antimicrobial functions of neutrophils from 
elderly people were also reported to be modified; reactive oxygen species (ROS) production 
after Staphylococcus aureus challenge was reduced, as was intracellular bacterial killing 
capacity (Di Lorenzo, et al., 1999, Wenisch, et al., 2000). Neutrophils can expel neutrophil 
extracellular traps (NETs), which are composed of chromatinized DNA and antimicrobial 
proteins, to immobilize and destroy extracellular pathogens. Impaired NET formation was 
reported in neutrophils from elderly donors (Hazeldine, et al., 2014). As NET formation is 
dependent upon NADPH oxidase activity (Fuchs, et al., 2007), this effect could be another 
consequence of decreased ROS production. Similarly, Tseng et al (Tseng, et al., 2012) 
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showed that old mice infected with S. aureus displayed impaired NET production, low 
production of certain chemokines (CXCL1, MIP-2 and KC), and reduced neutrophil 
recruitment to the site of infection. Reduced chemotaxis of neutrophils from healthy older 
subjects was also described by Sapey et al (Sapey, et al., 2014). In this case, the effect was 
linked to the basal activation state of phosphoinositide 3-kinase. Interestingly, inhibition of 
this kinase restored efficient chemotaxis. Reduced production of chemokines such as IL-8, as 
well as other defects in cell functions, have also been linked to reduced neutrophil expression 
of Toll-like Receptor (TLR)1 in adults over the age of 65, as compared to those from adults 
aged between 21 to 30 years (Qian, et al., 2014). Thus, many important neutrophil functions 
deteriorate during ageing. 
 
Through their capacity to recognize absent or altered major histocompatibility complex 
(MHC) class I expression, natural killer (NK) cells can detect and destroy virus-infected or 
tumor cells. Age-associated changes in NK cells in the elderly have been extensively 
documented by Mocchegiani et al (Mocchegiani and Malavolta, 2004). One of the major 
differences is that the elderly reportedly have an increased number of total NK cells in their 
blood (Plackett, et al., 2004). More precisely, there is an increase in the CD56-CD16+ 
subpopulation, but a decrease in the CD56bright subset (Le Garff-Tavernier, et al., 2010). 
Nonetheless, this increase in total NK numbers is counterbalanced by a decrease in the 
cytotoxic activity per cell (Campos, et al., 2014). This suggests that the increase in number 
may actually reflect a regulatory mechanism that is attempting to restore appropriate NK 
functions. Declining NK cell function likely relates to lower levels of perforin (Rukavina, et 
al., 1998), as well as reduced production of interferon (IFN)-γ, chemokines and ROS 
(Borrego, et al., 1999, Di Lorenzo, et al., 1999, Mariani, et al., 2002, Solana and Mariani, 
2000). These age-related perturbations in NK cell functions may contribute to several age-
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related diseases. For example, impaired NK functions in the elderly have been associated 
with a higher incidence of infection (Ogata, et al., 2001). Similarly, patients with acute 
myeloid leukemia under the age of 65 years had reduced expression of CD226 (DNAM-1) on 
their NK cells, as compared to those of healthy subjects (Sanchez-Correa, et al., 2012). As 
CD226 is involved in the activation of NK cell-mediated cytotoxicity, older subjects may be 
at risk of having less efficient anti-tumor immune responses. These examples highlight that 
NK cells from the elderly can display similar phenotypes to those of some cancer patients, 
which might contribute to impaired tumour surveillance by these cells. Crosstalk between 
splenic dendritic cells (DC) and NK cells from C57BL/6 mice was also altered with ageing. 
DC from 80 to 120 week old mice could not activate NKs from either young or old mice, 
whereas those from 8 to 12 week old mice could efficiently trigger CD69 expression and 
IFN-γ production by NK cells (Guo, et al., 2014). Thus, impaired DC functions may 
contribute to a decline in NK cell functions during ageing. In view of the clear links between 
ageing and NK cell function, future studies may well identify differences in numbers or 
functions of other innate-like lymphocytes such as ILC22, ILC17 and/or type 2 ILC (Hwang 
and McKenzie, 2013) during ageing. This seems plausible given that these cells are at the 
cross-roads between innate and adaptive immunity, and have been linked with various 
autoimmune and inflammatory diseases (Monticelli, et al., 2012, Sonnenberg, 2014), 
conditions that are commonly found in elderly people.  
 
Monocytes account for approximately 5% of the white blood cell population. These cells can 
differentiate into macrophages and DC to replenish certain tissue resident populations during 
homeostasis and inflammation. There is no clear consensus on the effects of ageing on DC 
subsets. Some have reported a decrease in numbers of myeloid DC, but not plasmacytoid DC 
(pDC), in the elderly (Della Bella, et al., 2007). Others reported that numbers of pDC, but not 
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myeloid DC, declined with age and that only frail elderly people showed a decrease in their 
myeloid DC numbers (Jing, et al., 2009, Perez-Cabezas, et al., 2007). These reports are of 
particular interest, given that pDC are major producers of type I IFN, and that type I IFN 
negatively regulates inflammasome responses (see Section 4.3). Although monocyte numbers 
do not appear to be substantially altered in the elderly, the non-classical CD14+CD16+ 
monocyte subpopulation was reported to increase significantly during ageing (Seidler, et al., 
2010). Importantly, recent studies have documented that tissue macrophage populations can 
also arise independently of monocytes. During embryogenesis, embryonic phagocytes seed 
specific tissues to provide the precursors for several tissue-resident macrophage populations 
in the adult, under homeostatic conditions (Guilliams, et al., 2013, Perdiguero, et al., 2014, 
Schulz, et al., 2012). Nonetheless, under conditions of stress as occurs during infection, 
inflammation and ageing, inflammatory monocytes contribute substantially to the pool of 
tissue-resident macrophages (Ginhoux and Jung, 2014, Zigmond, et al., 2012). Thus, 
functional differences between embryonic phagocyte-derived versus monocyte-derived 
macrophages may contribute to altered tissue macrophage functions during ageing.  
 
Numerous studies have documented age-related perturbations in macrophage functions, 
including phagocytosis, cytokine production, regulation of wound healing and antigen 
presentation. Phagocytotic activity of Kupffer cells (tissue resident macrophages of the liver) 
and peritoneal macrophages was reported to be reduced in aged rats (Izgut-Uysal, et al., 
2004, Sun, et al., 1998). However, not all macrophage populations share this phenotype. 
Another study showed that peritoneal macrophages from aged mice also had impaired 
phagocytic activity, whereas this was not the case for bone-marrow derived macrophages 
(Linehan, et al., 2014). Similarly, Mancuso et al (Mancuso, et al., 2001) showed that, in aged 
rats, phagocytic activity of recruited polymorphonuclear leukocytes was impaired, whereas 
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that of resident alveolar macrophages was actually substantially increased. Given that recent 
evidence suggests that a substantial proportion of resident alveolar macrophages are derived 
from embryonic phagocytes (Guilliams, et al., 2013), differential effects of ageing on 
phagocytic capacity between macrophage populations could reflect differences in ontogeny 
(e.g. embryonic- versus haematopoietic stem cell-derived). 
 
In addition to changes in phagocytic capacity, ageing generally leads to reprogramming of 
macrophage responsiveness to inflammatory stimuli. For example, macrophages from aged 
mice produced less lipopolysaccharide (LPS)-induced IL-6, TNF, IL-1β and IL-12, which 
was linked to an elevation in LPS-induced IL-10 production (Chelvarajan, et al., 2005). In 
contrast, another group linked the age-related impairment of LPS responses in macrophages 
from C57BL/6 mice to reduced protein expression of CD14, a TLR4 co-receptor (Vega, et 
al., 2004). Interestingly, the surface expression of TLR4 on macrophages did not vary when 
comparing peritoneal cells from young (2-3 months) and aged BALB/c (> 18 month) mice 
(Boehmer, et al., 2004), whereas it was decreased in aged C57Bl/6 mice (Renshaw, et al., 
2002). Whilst the findings from these studies cannot be directly compared, it does raise the 
possibility that genetic background may impact on immune phenotypes during ageing. In 
human monocytes, differences in cellular responses from young (21 to 30 years) versus 
elderly (>65 years) donors depended on the specific TLR being triggered (van Duin, et al., 
2007). A strong age-associated impairment in TLR1/2-induced TNF and IL-6 production was 
evident, whereas other TLR-induced cytokine responses (including TLR2/6) remained intact. 
The authors proposed that decreased surface expression of TLR1 was causal for this, which is 
consistent with more recent findings in neutrophils (Qian, et al., 2014). Reprogrammed 
macrophage cytokine secretion profiles during ageing may also have relevance to 
immunosuppression during cancer progression (Jackaman and Nelson, 2014). Recent work 
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from Nelson and colleagues (Jackaman, et al., 2013) showed that macrophages from aged 
mice show an M2-skewed phenotype and produce higher levels of TGF-β in response to IL-4. 
In addition, only macrophages from aged mice produced IL-4 in the presence of lung 
carcinoma tumor cell-derived supernatants. This would suggest that tumour-associated 
macrophages in elderly patients may have a more pronounced immunosuppressive 
phenotype. Finally, macrophages from young but not old mice could promote IFN-γ 
production from T-cells, but targeting macrophages from aged mice with IL-2/CD40 could 
rescue T-cell production of IFN-γ (Jackaman, et al., 2014). Thus, immunomodulation 
strategies could potentially overcome the immunosuppressive phenotype of tumour-
associated macrophages in the elderly. 
 
Resident macrophages play an important role in skin homeostasis and wound healing. 
Thomas et al (Thomas, 2001) reported an age-associated decrease in wound repair in the skin 
in both human and mouse. This was linked to a delay in most steps of the wound repair 
process: cellular infiltration, collagen deposition, angiogenesis and re-epithelialisation. 
Intriguingly, this healing delay could be overcome by administration of peritoneal 
macrophages isolated from young mice, whereas macrophages from old mice did not 
improve healing (Danon, et al., 1989). This effect could be partially explained by an age-
related decrease in the production by macrophages of vascular endothelial growth factor 
(Swift, et al., 1999), a key angiogenesis factor required for wound healing. More recent work 
has shown that efficient wound healing could be restored in aged mice by using activated 
mesenchymal stem cells, and that this effect was dependent on macrophage activity (Lee, et 
al., 2013). 
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Finally, antigen presenting capacity of myeloid cells is impaired in the elderly. For example, 
when used as antigen presenting cells (APC), thioglycollate-elicited peritoneal macrophages 
from aged C57BL/6 mice (18–26 month old) required more time to induce CD8+ T cell 
clonal expansion and induced lower levels of IFN-γ secretion, as compared to macrophages 
from 8–12 week old mice (Donnini, et al., 2002, Plowden, et al., 2004). This effect was 
solely dependent on the APC, as T cells from aged mice showed no defect when the APC 
were derived from young mice. At least one mechanism that could account for impaired 
antigen presentation capacity is an age-related decline in IFN-γ-stimulated expression of 
MHC class II in macrophages (Herrero, et al., 2001), at least in the C57BL/6 mouse. Another 
study showed that levels of MHC I and II on macrophages from young versus old BALB/c 
mice were not significantly different, again raising the possibility that genetic background 
influences immune perturbations during ageing. There is currently limited data on the effect 
of ageing on antigen presentation in humans. One study found that in vitro-derived DC from 
young (<30 years) versus old (>65 years) individuals did not differ in phenotype or functional 
capacity, although increased DC numbers were consistently generated from the older 
individuals (Steger, et al., 1996). However, whether these findings with in vitro differentiated 
DC reflect in vivo functions of DC during ageing is an open question.  
 
2.3 Age-related increases in soluble innate immune inflammatory mediators 
The general aged-associated hyporesponsiveness of innate immune cells, particularly 
macrophages, contrasts with the increased levels of certain pro-inflammatory mediators, such 
as IL-6, IL-1β, IL-18 and TNF, in the blood and/or specific tissues in the elderly. High levels 
of IL-6 at homeostasis in the elderly are such a consistent finding that IL-6 has been 
described as the “cytokine for gerontologists” (Ershler, 1993, Ershler and Keller, 2000). 
Serum concentrations of IL-6 also correlate with disease severity for some inflammatory 
13 
 
diseases, for example in sepsis (Damas, et al., 1992). Therefore, IL-6 might be viewed as a 
marker of declining health, either through illness or ageing. Indeed, elevated levels of IL-6, 
as well as C reactive protein (CRP), correlated with mortality in a study of more than 1200 
healthy participants over the age of 65 years (Harris, et al., 1999). The value of other 
inflammatory mediators such as TNF as predictors of health status is still unclear. For 
example, a study by Bruunsgaard et al (Bruunsgaard, et al., 2003a) reported that, in the case 
of centenarians, TNF serum levels were a prognostic marker for mortality. However, similar 
work from the same author found that, in a cohort of 80 year-old people, TNF levels 
correlated with mortality after 6 years only in males, whereas IL-6 was a good mortality 
marker in both males and females (Bruunsgaard, et al., 2003b). More recent work from 
Giovanni et al (Giovannini, et al., 2011) confirmed that TNF, IL-6 and CRP levels were 
associated with a significantly increased risk of death in the elderly, but TNF concentrations 
was no longer significant when adjusting for confounding effects such as age, sex and clinical 
variables. Another study reported that the combination of high levels of IL-6 and low levels 
of insulin-like growth factor increased the risk of disability and death in elderly women 
(Cappola, et al., 2003). Not surprisingly, this suggests that combinatorial perturbations of 
biological pathways impact age-associated pathologies. Yet another inflammatory mediator 
linked with declining health during ageing is macrophage inhibitory cytokine-1 (MIC-
1/GDF15), a cytokine involved in inflammation and healing. A recent analysis of a cohort of 
876 male subjects from 35 to 80 years old, correlated MIC-1 serum levels with all-cause 
mortality (Wiklund, et al., 2010).  
 
Whilst the correlation between declining health during ageing and increased levels of certain 
inflammatory mediators such as IL-6 has been appreciated for many years, there is growing 
interest in the contribution of the inflammasome-dependent cytokines IL-1β and IL-18 in 
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age-associated pathology (Dinarello, 2006). This is underscored by the recent finding that 
activation of nod-like receptor pyrin-containing domain (NLRP) 3 was linked to systemic, 
low-grade, age-associated "sterile" inflammation (see Section 4.1), leading to the production 
of IL-1β (Youm, et al., 2013). Importantly, the authors found that animals lacking either 
Nlrp3 or the IL-1 receptor were partially protected against age-related functional decline. 
There is certainly evidence for increased levels of IL-1β and/or IL-18 in certain age-related 
conditions. For example, high serum levels of IL-1β were been reported in patients with 
Alzheimer's disease (Licastro, et al., 2000). Although assessed in only a small patient cohort, 
the presence of IL-1β in the cerebrospinal fluid of elderly patients recovering from hip 
surgery was also found to correlate with the incidence of delirium (Cape, et al., 2014). IL-1β 
mRNA expression also increased in adipose tissue of aged (23 month) mice, as compared to 
2 month old mice (Youm, et al., 2013). Griffin et al (Griffin, et al., 2013) found that IL-1β 
antagonism, via systemic administration of IL-1RA, improved cognitive function in a LPS-
induced mouse model of cognitive decline. Similarly, as compared to aged wild type mice, 
motor performance and cognitive function was enhanced in aged Il1r -/- mice (Youm, et al., 
2013). Collectively, these studies support a role for IL-1β in age-associated cognitive 
impairment. Mechanistically, a recent study in mice has demonstrated that IL-1β and IL-1R 
expression was increased during ageing, and this was linked to an enhanced capacity to 
generate pathogenic Th17 cells (Lim, et al., 2014). Whereas IL-1β likely contributes to 
neuroinflammation and a decline in cognitive function during ageing, recent studies have 
linked IL-18 to cardiovascular-related pathology. IL-18 was associated with heart failure in a 
cohort of 2,917 men and women aged between 70-79 years (Driver, et al., 2014). In addition, 
artery injuries in old rats showed increased fibrinogen deposition that correlated with 
increased vascular IL-18. The authors found that levels of IL-18 in the injured vasculature 
were more than 23-fold higher in aged rats than in young rats (Rodriguez-Menocal, et al., 
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2014). IL-18 may also contribute to a decline in bone and joint function during ageing. For 
example, using 10 and 24 week old mice constitutively overproducing IL-18 in the lungs, 
Takenaka et al (Takenaka, et al., 2014) demonstrated an age-related decrease in body weight 
and bone mineral density in IL-18 transgenic mice, as compared to wild-type controls. In 
summary, unhealthy ageing is associated with elevated levels of specific pro-inflammatory 
mediators such as IL-6, and IL-1β and IL-18 are likely contributors to specific pathological 
processes during ageing (Michaud, et al., 2013).  
 
2.4 Chronic low-grade inflammation as a driver of unhealthy inflammation 
Many mechanisms have been proposed to contribute to unhealthy ageing. These include the 
effects of diet and postprandial inflammation, a cumulative effect of reactive oxygen species 
leading to DNA damage, and the role of the growth hormone/insulin-like growth factor axis 
(Finch, 2010, Junnila, et al., 2013, Wei, 1998). Many of the proposed mechanisms share the 
concept that a chronic, basal inflammatory state plays a causal role. In 2000, Claudio 
Franceschi, arguing that ageing was the source of a stress response leading to chronic 
inflammation, coined the term inflam-ageing (Franceschi, et al., 2000). His hypothesis 
proposed two paradoxical characteristics of ageing. On the one hand, immune cells produce 
less pro-inflammatory cytokines, yet more inflammatory mediators are present in the 
organism at a basal level. Indeed, this apparent paradox is evident in the literature reviewed 
in Sections 2.2 and 2.3 above. Inflammatory mediator production by non-immune cells such 
as adipose tissue could account for such effects (Wu, et al., 2007). Another possibility is that 
whilst many innate immune responses are impaired during ageing, others are hyper-activated. 
Below we review the evidence that dysregulated inflammasome activation, through elevated 
levels of danger signals as well as defects in normal regulatory mechanisms, leads to chronic, 
low-grade, pathological inflammation during ageing. 
16 
 
3. Inflammasome dysregulation in ageing 
3.1 MAMPs and DAMPs in the link between ageing and inflammation 
Innate immune cells are finely tuned for sensing changes in the extracellular environment. 
They do so though cell surface and intracellular receptors that detect cytokines, chemokines, 
peptide mediators, lipid mediators and metabolites, as well as danger signals in the form of 
endogenous DAMPs and exogenous MAMPs. Several families of PRRs, some of which can 
form inflammasomes (see Section 3.2), detect these MAMPs and DAMPs. An obvious 
mechanism that could account for increased inflammatory responses at the organismal level 
during ageing is dysregulated PRR responses via increased levels of MAMPs and/or DAMPs. 
Age-associated increases in MAMPs can occur through gut leakage. It is now well 
established that during stress, bacterial products (e.g. endotoxin and peptidoglycan) can be 
translocated from the intestinal tract to the circulatory system (Gatt, et al., 2007). Indeed, gut 
leakage occurring during the course of abdominal aortic surgery correlated with an increase 
in plasma levels of IL-6 and CRP (Kim, et al., 2009). Moreover, ageing has been linked with 
impaired function of the gut mucosa (Fujihashi, et al., 2000, Meier and Sturm, 2009). For 
example, a study comparing young and old rats (3 and 28 months) reported that ageing 
increased gut permeability, as assessed by increased intestinal permeability of the probes 
mannitol and PEG 400 (Ma, et al., 1992). In addition to differences in the permeability of the 
intestinal tract, age can potentially impact on the level of response that occurs when bacterial 
products access the circulation. For example, the elderly displayed a prolonged fever 
response, enhanced production level of TNF, and a more profound decrease in arterial 
pressure during endotoxemia (Krabbe, et al., 2001, Krabbe, et al., 2001). Thus, it is 
reasonable to conclude that elevated levels of MAMPs can contribute to systemic 
inflammatory effects during ageing. 
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Host-derived DAMPs provide an additional mechanism of age-related innate immune 
activation. The literature on specific host-derived DAMPs driving inflammation has been 
somewhat clouded by the fact that DAMP preparations used to investigate pro-inflammatory 
effects can sometimes be contaminated with bacterial products, such as endotoxin (Tsan and 
Gao, 2007). For example, heat-shock protein 60 was originally described as an endogenous 
host factor that signalled via TLRs (Bulut, et al., 2002, Kol, et al., 1999, Ohashi, et al., 2000), 
but subsequent studies raised concerns about possible endotoxin contamination of the heat 
shock protein preparations as the likely mediator of such effects (Bausinger, et al., 2002, Gao 
and Tsan, 2003). CRP, the concentration of which increases during ageing, was similarly 
shown to activate endothelial cells (Blann and Lip, 2003, Pasceri, et al., 2000, Venugopal, et 
al., 2002), but multiple groups raised similar concerns about contaminating endotoxin 
(Nerurkar, et al., 2005, Taylor, et al., 2005). Such examples highlight possible complications 
of interpreting data that show pro-inflammatory effects of specific DAMPs, and the need for 
extreme rigour in sample preparation and analysis, for example the use of the limulus 
amebocyte lysate assay to assay levels of endotoxin (Levin and Bang, 1968), purification 
methods that remove contaminating LPS (Ongkudon, et al., 2012), the use of polymyxin B 
sulphate as an LPS antagonist (Duff and Atkins, 1982, Palmer and Rifkind, 1974), and crude 
biochemical methods such as protease-treatment and/or boiling. However, even these 
methods are not fail-safe. For example, low LPS concentrations are also rendered inactive by 
boiling (Gao, et al., 2006) and non-LPS contaminants such as bacterial lipoproteins are often 
a major issue. Moreover, when one is considering whether a particular DAMP acts through a 
PRR already known to directly recognize a specific MAMP, the structural features of that 
DAMP should be considered. For example, TLR4 detects the lipid A region of LPS. Thus, it 
is difficult to understand how a protein alone would directly signal via this receptor unless it 
can initiate receptor dimerization by a distinct mechanism, for example through an allosteric 
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site. Alternatively, it may be that the protein in question presents lipid A, or a lipid A-like 
molecule, to TLR4. Indeed, this is a recurring theme in PRR biology. As two examples of 
this, mouse mammary tumour virus was reported to present LPS for recognition by TLR4 as 
part of its host evasion strategy (Kane, et al., 2011), and hemozoin produced during 
Plasmodium infections presents parasite DNA for recognition by TLR9 (Parroche, et al., 
2007). Despite these significant issues, an abundant literature has described many DAMPs 
that can directly or indirectly activate specific PRRs. 
 
Well-characterized DAMPs, among many, that can signal through non-inflammasome 
forming PRRs include oxidised low density lipoproteins and Aβ that signal via TLR4 and 
TLR6 (Bae, et al., 2009, Miller, et al., 2003, Stewart, et al., 2010), as well as the extracellular 
matrix protein versican (Kim, et al., 2009) and serum amyloid A (Cheng, et al., 2008, He, et 
al., 2009) that signal through TLR2. Another extensively studied DAMP is high-mobility 
group protein B1 (HMGB1), a nuclear protein that binds to nucleosomes and controls DNA 
bending and gene expression (Kang, et al., 2014). Its release into the extracellular 
environment, indicative of cell damage or death, can lead to PRR-dependent inflammatory 
responses. HMGB1 has been reported to signal via multiple PRRs, through either direct 
recognition or through interaction with specific PAMPs (Bianchi, 2009). Reported signalling 
mechanisms include (1) forming a complex with dsDNA to signal through TLR9 (Ivanov, et 
al., 2007, Tian, et al., 2007); (2) binding to the lipid A moiety of LPS, resulting in 
disaggregation from the cell membrane and transfer to CD14 for signalling through TLR4 
(Youn, et al., 2008); (3) directly binding TLR2 to initiate inflammatory responses (Park, et 
al., 2006, Park, et al., 2004); and (4) interacting with the receptor for advanced glycation end 
products (RAGE) (LeBlanc, et al., 2014). RAGE is a multi-ligand receptor that was initially 
identified as a receptor for advanced glycation end products (Bierhaus, et al., 2005, Schmidt, 
19 
 
et al., 1992). RAGE has itself been reported to bind multiple DAMPs apart from HMGB1, for 
example members of the S100 family of proteins (Hofmann, et al., 1999). Thus, DAMPs and 
their receptors appear to be particularly promiscuous in the mechanisms by which they drive 
inflammatory responses, albeit with the caveats regarding MAMP contamination (described 
above). 
 
3.2 Inflammasome-driven inflammatory responses 
In response to certain DAMPs and MAMPs, some PRRs can initiate the formation of an 
“inflammasome”, a cytosolic signalling platform (Latz, et al., 2013, Martinon, et al., 2002). 
When activated, these signalling hubs trigger the activation of certain inflammatory caspases, 
most notably caspase-1, through auto-cleavage. Activated caspase-1 in turn cleaves pro-
forms of the inflammatory cytokines IL-1β and IL-18 to enable their release into the 
extracellular environment. Through unknown mechanisms, caspase-1 also triggers an 
inflammatory form of cell death known as pyroptosis. To date, a sub-set of Nod-like 
Receptors (NLRP1, NLRP3, NLRC4), the Pyhin family member AIM2 and Pyrin have been 
shown to be capable of forming functional inflammasomes (Schroder and Tschopp, 2010). Of 
these, NLRP3 has been the most widely studied. NLRP3 contains a C terminal leucine rich 
repeat (LRR) domain involved in ligand recognition, a central NACHT domain that defines 
the family and an N-terminal pyrin domain (PYD) (Sutterwala, et al., 2014) (Figure 3). Upon 
activation, the PYD of NLRP3 recruits the PYD-containing protein apoptosis-associated 
speck-like protein containing a caspase recruitment domain (ASC) through homotypic 
interactions. ASC then recruits pro-caspase 1, again through homotypic (CARD-CARD) 
interactions, to enable auto-activation of this protease and the initiation of downstream 
signalling. 
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Whilst the activation of caspase-1 was originally thought to be the hallmark of inflammasome 
activation, more recent studies have identified a non-canonical, caspase-1-independent 
inflammasome pathway. In mice, this involves activation of caspase 11 (Kayagaki, et al., 
2011). This study found that Casp1-/- mice were also deficient in caspase-11, because 129/Sv 
mice (the background on which the Casp1 knock-out was originally generated) have a natural 
deficiency in Casp11. Subsequent studies demonstrated that caspase-11 was required for 
inflammasome activation in response to cytosolic LPS (Hagar, et al., 2013, Kayagaki, et al., 
2013, Shi, et al., 2014), and a very recent study has shown that the CARD of caspase-11 
directly detects cytosolic LPS (Shi, et al., 2014). Caspase-4 and caspase-5 are the human 
homologues of mouse caspase-11, and a functional role for caspase-4 in detecting cytosolic 
LPS in human cells has also been demonstrated (Shi, et al., 2014). Thus, the signalling 
pathways initiated upon inflammasome activation are not simply a linear series of events 
downstream of caspase-1. 
 
Inflammasome activation is usually studied in the context of priming and triggering signals. 
A priming signal, for example through TLR signalling, upregulates the expression of 
inflammasome signalling components such as Nlrp3 (Bauernfeind, et al., 2009). Priming is 
also needed for the inducible expression of inflammasome target proteins, most notably pro-
IL-1β (Bauernfeind, et al., 2009). However, priming signals can also act independently of 
transcriptional induction of inflammasome components and target proteins. For example, 
acute LPS stimulation still primed NLRP3 responses prior to increasing expression of 
NLRP3 protein (Schroder, et al., 2012). In most cases, the specific mechanisms that mediate 
inflammasome activation in response to the trigger signal are poorly understood. In the case 
of NLRP3, this PRR can be activated by many chemically distinct stimuli, acting through 
diverse mechanisms. For example, ATP-mediated NLRP3 inflammasome activation requires 
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signalling through the P2X7 receptor (Kahlenberg, et al., 2005), whereas pore-forming toxins 
such as nigericin act independently of this receptor (Mariathasan, et al., 2006).  
 
The diversity of agents that can trigger activation of NLRP3 suggests that several 
mechanisms can lead to activation of this PRR or that all signals converge in the generation 
of a particular cell stress that is sensed by NLRP3. Several mechanisms have been reported, 
including ROS-mediated Nlrp3 activation (Heid, et al., 2013), potassium efflux-dependent 
activation of Nlrp3 (Munoz-Planillo, et al., 2013), oxidised mitochondrial DNA-mediated 
Nlrp3 activation in response to mitochondrial damage (Shimada, et al., 2012), and cathepsin 
B-mediated NLRP3 activation in response to phagosomal rupture (Dostert, et al., 2009, 
Hornung, et al., 2008). At a molecular level, the mechanisms by which these pathways could 
lead to NLRP3 activation are still not well understood, though progress is beginning to be 
made. For example, ROS-dependent deubiquitination of Nlrp3 has been linked to clustering 
and activation of this receptor (Juliana, et al., 2012).  
 
4. Age-related factors contributing to Inflammasome dysregulation and Inflam-ageing  
4.1 The evidence for a causal role of inflammasome activation in age-related health decline 
Since IL1β and IL-18 have been associated with age-related pathologies (Section 2.3), this 
raises the possibility that inflammasome activation may have some role in health decline 
during ageing. Most existing evidence posits NLRP3 as the relevant inflammasome-
triggering PRR in this context. Two studies in mouse models are particularly important in this 
regard. Firstly, Youm et al (Youm, et al., 2012) showed that Nlrp3 plays a causal role in 
thymic atrophy. Specifically, this study demonstrated that free cholesterol and ceramides 
accumulated in the thymus of aged mice, and this was associated with inflammasome 
activation in this organ. Moreover, mice deficient in either Nlrp3 or Asc were protected from 
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thymic involution, contraction of the T cell receptor repertoire and immune senescence. A 
subsequent study by the same group (Youm, et al., 2013) showed that 23 month old Nlrp3-/- 
mice had improved glucose tolerance as compared to wild type mice and that age-associated 
increases in Il-1β mRNA expression in adipose tissue and serum IL-18 levels were 
completely or partially dependent on Nlrp3, respectively. Astrogliosis, a pathological 
increase in astrocytes that contributes to age-related functional decline (Ransohoff and 
Brown, 2012), was reduced in Nlrp3-/- mice. Microarray profiling of the hippocampal region 
of Nlrp3-/- versus wild type mice also revealed that age-related increases in inflammatory and 
cell death genes were dependent upon Nlrp3. Nlrp3-/- mice were also protected from 
cognitive decline and bone loss during ageing. These mouse model studies therefore highlight 
a key contribution of the Nlrp3 inflammasome to age-related features of health decline.  
 
4.2 Inflammasome dysregulation through DAMP accumulation 
An obvious mechanism that could contribute to pathological inflammasome activation during 
ageing is the build up of stimuli that trigger activation of the NLRP3 pathway. Several host 
products that accumulate during ageing have been characterized as inflammasome activators. 
These include lipotoxins such as ceramides (Youm, et al., 2012), serum amyloid A (Ather, et 
al., 2011, Niemi, et al., 2011), cholesterol crystals (Abela, 2010, Duewell, et al., 2010), Aβ 
(Halle, et al., 2008) and islet amyloid polypeptide (Masters, et al., 2010). For the purposes of 
this review, we provide a brief overview of just two ageing-associated inflammasome 
activators, uric acid (UA) and ROS, as specific examples of factors that may contribute to 
dysregulated inflammasome activation.  
 
UA, the end product of the cellular catabolism of purines, is present in body fluids and at 
much higher concentrations in the cytosol of healthy cells. When extracellular UA comes into 
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contact with the high levels of free sodium that are present in the extracellular environment, it 
is believed to nucleate and form monosodium urate (MSU) crystals (Chen, et al., 2006). MSU 
crystals were first identified in gout patients in the 18th century (Wollaston, 1797). In more 
recent times, MSU was shown to trigger the activation of the NLRP3 inflammasome and the 
production of IL-1β (Martinon, et al., 2006). Indeed, macrophages from mice deficient in 
inflammasome components such as caspase-1, NLRP3 and ASC, displayed a greatly reduced 
capacity for MSU-induced IL-1β production (Amaral, et al., 2012). Targeting of the IL-1 axis 
in gout, with initial clinical trials of the IL-1R antagonist Anakinra, has shown remarkable 
efficacy (McGonagle, et al., 2008, McGonagle, et al., 2007, So, et al., 2007). Similarly, 
patients with pseudogout, an inflammatory disease caused by the deposition of calcium 
pyrophosphate dihydrate crystals (Bennett, et al., 1976), another type of pathogenic 
microcrystal that activates the NALP3 inflammasome, responded well to IL-1 antagonism 
(McGonagle, et al., 2008). These findings are of interest in view of the evidence linking MSU 
accumulation with ageing. For example, a longitudinal study among 80,506 Japanese office 
workers or their families between 1989-1998 showed that serum UA levels progressively 
increased with age, independent of changes in alcohol consumption and body mass index 
over the period of assessment (Kuzuya, et al., 2002). In addition to its causal role in gout, 
high levels of circulating UA (hyperuricemia) have been associated with various 
inflammatory diseases, IgA nephropathy (Moriyama, et al., 2014), hypertension (Luo, et al., 
2014, Nagahama, et al., 2014) and multiple sclerosis (Moccia, et al., 2014). However, 
whether the hyperuricemia is a cause or consequence of the disease is still unclear in most of 
these conditions. Nonetheless, the accumulation of MSU crystals provides one mechanism 
for inappropriate inflammasome activation during ageing. 
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ROS have widely been proposed to contribute to the development of many age-related 
disorders, including atherosclerosis and other cardiovascular diseases (Bonomini, et al., 2008, 
Griendling and Alexander, 1997), diabetes (Kaneto, et al., 2007), cancer (Benz and Yau, 
2008), neurodegenerative disorders (Barnham, et al., 2004), and chronic diseases of the liver 
(Webb and Twedt, 2008) and lung (Park, et al., 2009). ROS produced by the respiratory 
chain of mitochondria is primarily generated via complex I (NADH coenzyme Q reductase), 
though complex III (cytochrome c reductase) can also contribute under certain conditions 
(Murphy, 2009). Damage by ROS results in lipid peroxidation (Gardner, 1989), protein 
oxidation (Stadtman, 1990) and mitochondrial DNA mutations (Richter, 1992, Richter, et al., 
1988). A possible link between oxidized mitochondrial DNA fragments and ageing was 
proposed in 1988 (Richter, 1988), and since then, developments in the field have provided 
further evidence of the role of ROS, as reviewed recently by Zapico and Ubelaker (Zapico 
and Ubelaker, 2013). In the context of inflammasome activation, ROS appear to be involved 
in NLRP3 activation in response to multiple stimuli (Cruz, et al., 2007, Dostert, et al., 2008, 
Jiang, et al., 2012, Joshi, et al., 2014).  Baurenfeind et al (Bauernfeind, et al., 2011) showed 
that diphenyliodonium, an inhibitor of NADPH oxidase-dependent ROS production, impaired 
LPS-mediated upregulation of Nlrp3 mRNA in mouse macrophages. In addition, 
diphenyliodonium only decreased Nlrp3-triggered IL-18 and IL-1β production when cells 
were exposed to this agent prior to LPS stimulation, and not after. Although this suggests that 
ROS contributes solely to priming of inflammasome responses, several other studies have 
provided evidence for causal roles of ROS in triggering inflammasome activation. Zhou et al 
(Zhou, et al., 2011) showed that mitochondrial ROS can trigger NLRP3 activation, and that 
the voltage-dependent anion channel was essential for this response. Another report provided 
evidence that mitochondrial ROS-mediated inflammasome activation involved oxidation of 
mitochondrial DNA, which was then directly sensed by Nlrp3 (Shimada, et al., 2012). 
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Another study also reported that mitochondrial ROS mediates cathepsin B release from 
damaged lysosomes, thus resulting in Nlrp3 activation (Heid, et al., 2013). In summary, 
evidence for a link between ROS generation and inflammasome priming and/or activation 
continues to accumulate. Thus, increased or sustained production of ROS could contribute to 
dysregulated inflammasome activation during ageing and chronic inflammation.  
 
4.3 Inflammasome dysregulation through a failure in control mechanisms 
An additional mechanism by which dysregulated inflammasome activation could occur 
during ageing is through loss of regulatory control mechanisms. For example, type I IFN 
negatively regulates the Nlrp1 and Nlrp3 inflammasomes (Guarda, et al., 2011). This is of 
interest given that type I IFN producing pDC are reported to decline in numbers with age 
(Jing, et al., 2009). Moreover, pDC from aged mice (>18 months), as compared to 2 month 
old mice, produced less type I IFN in response to TLR9 activation (Stout-Delgado, et al., 
2008). This age-associated defect in type I IFN production was also apparent in West Nile 
virus-infected human DC (73 year old versus 25 year old donors) (Qian, et al., 2011). Hence, 
impaired type I IFN production during ageing could conceivably lead to defective control of 
inflammasome activation. This remains to be tested. 
 
Another possible mechanism that could lead to inappropriate inflammasome activation 
during ageing is impaired autophagy. Autophagy (from the Greek words “auto”: self and 
“phago”: eating) was first described in 1963 by Nobel-prize laureate Christian de Duve (De 
Duve and Wattiaux, 1966), although dense intracellular bodies that may have been 
autophagosomes were observed a few years earlier (Ashford and Porter, 1962, Hruban, et al., 
1963). This cellular pathway involves the degradation of cellular components or intracellular 
microbes enclosed in an autophagosome, a double membrane structure (Deretic, et al., 2013). 
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This structure then fuses with a lysosome to form an autolysosome, an efficient degradation 
system. Autophagy is involved in diverse physiological and pathophysiological processes, 
and thus its dysregulation has been linked to numerous diseases (Mizumura, et al., 2014). 
 
Several studies have implicated autophagy in negative regulation of inflammasome responses 
(Salminen, et al., 2012). One of the first demonstrations of a link between autophagy and 
inflammasome activation came from the work of Akira and colleagues, who showed that 
macrophages from mice lacking an essential autophagy protein Atg16L1 produced elevated 
levels of IL-1β and IL-18 in response to TLR activation (Saitoh, et al., 2008). More recent 
studies suggest that autophagy regulates inflammation by destroying ubiquitinated 
inflammasome components, as well as pro-IL-1β, thus preventing inflammasome activation 
and IL-1β maturation (Harris, et al., 2011, Shi, et al., 2012). Inflammasome activation and 
metabolism are intrinsically linked, in particular with respect to mitochondrial activity 
(Green, et al., 2011). Zhou et al (Zhou, et al., 2011) showed that blockade of autophagy leads 
to an accumulation of damaged mitochondria within the cell, thus resulting in ROS-
dependent NLRP3 activation. In view of this literature, the strong link between ageing and 
autophagy is of particular interest. Inhibition of autophagy reduced the lifespan of many 
organisms such as C. elegans (Melendez, et al., 2003, Toth, et al., 2008), Drosophila 
melanogaster (Juhasz, et al., 2007, Simonsen, et al., 2008) and even mice (Harrison, et al., 
2009). In addition, there is also direct evidence that autophagy function decreases with age. 
Cuervo and Dice (Cuervo and Dice, 2000) showed that chaperone-mediated autophagy 
declines with age, mainly due to decreased levels of lysosome-associated membrane protein 
type 2a. Additionally, a genome-wide study revealed that autophagy-essential genes such as 
type III phosphatidylinositide 3-kinases are down-regulated during ageing (Lipinski, et al., 
2010), and a genetic screen in Saccharomyces cerevisiae also identified 10 autophagy-related 
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genes associated with an ageing defect in yeast (Matecic, et al., 2010). Collectively, these 
studies suggest that boosting autophagy function during ageing could potentially limit 
inflammasome responses and associated pathology, and increase lifespan. Indeed, long-term 
treatment with rapamycin, which activates autophagy (Kamada, et al., 2000), improved 
cognitive functions in old mice and this was associated with lower levels of IL-1β in the 
brain (Majumder, et al., 2012). 
 
5. Conclusion 
A recent WHO report indicated that, between 2000 and 2050, the number of over 65 year old 
adults is expected to double from 11% to 22%, reaching an absolute number of 2 billion 
people (WHO, 2012). Thus, new treatment modalities for diseases that are prevalent in the 
elderly are essential. It has long been appreciated that ageing is associated with dysregulation 
of certain innate immune functions and elevated levels of specific inflammatory mediators. 
However, evidence for causal roles of the inflammasome pathway in age-related health 
decline has only recently emerged through studies in mouse models. Most evidence points to 
the involvement of the Nlrp3 inflammasome, yet at least some of the increase in serum IL-18 
levels in aged mice was ASC-dependent but Nlrp3-independent (Youm, et al., 2013). 
Moreover, the same study showed that some age-related functional declines were Nlrp3-
dependent, but IL-1-independent. There are thus likely to be contributions from other 
inflammasomes and downstream mediators, beyond the NLRP3-IL-1β axis, in at least some 
aspects of pathological ageing. Nonetheless, direct or indirect targeting of NLRP3-dependent 
inflammasome responses may ultimately provide opportunities for the treatment and/or 
prevention of age-related diseases. Long term treatment regimes in animal models using 
pharmacological inhibitors of NLRP3, IL-1 and/or IL-18 antagonists, and/or novel autophagy 
activators are now required to determine efficacy, feasibility and possible complications of 
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such approaches. With respect to complications, host genetics and host microbiomes are 
likely to be key factors that will greatly influence how successful these approaches will be in 
individual people. These are important variables that will necessitate careful consideration in 
the future. Ultimately, time will tell if the ticking inflammasome time bomb can be 
deactivated for therapeutic benefit during ageing. 
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FIGURE LEGENDS  
Figure 1. Contribution of inflammasome dysregulation to inflam-ageing. Proposed model 
linking perturbed innate immune functions, DAMP accumulation and inflammasome 
dysregulation with age-associated health decline.  
 
Figure 2. Effect of ageing on blood cell populations. During ageing, numbers of different 
leukocyte populations do not dramatically change, with the exception of NK cells that 
increase in number and lymphocyte numbers that decrease. In contrast, many innate immune 
cellular functions such as pro-inflammatory cytokine production, phagocytosis and 
chemotaxis decline during ageing. 
 
Figure 3. The NLRP3 inflammasome is triggered by age-associated DAMPs. Age-related 
DAMPs activate the NLRP3 inflammasome, resulting in pyroptosis and the release of the 
pro-inflammatory cytokines IL-1β and IL-18. This in turn results in pathological low-grade 
inflammation. 
 
 
